COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021

Jun 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-06-01

Reporting Person: Ciaffoni Joseph (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	F	4672	$22.9	Disposed	273635	Direct
2021-06-01	Common Stock	M	16205	$8.22	Acquired	289840	Direct
2021-06-01	Common Stock	S	5376	$22.93	Disposed	284464	Direct
2021-06-01	Common Stock	S	10829	$23.33	Disposed	273635	Direct
2021-06-02	Common Stock	S	5861	$22.81	Disposed	267774	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Stock Option (Right to Purchase)	$8.22	M	16205	Disposed	2027-05-31	Common Stock (16205)	Direct

Footnotes

F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.79 to $22.99, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4).

F4: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.88, inclusive.

F5: All of the 16,205 option shares are exercisable.